Interactive and Electronic Contract Manufacturing

Interactive contract manufacturing (ICM) is a neologism to describe the business model of companies that design, build, and deliver interactive assets for their business partners. In this model, advertising agencies team with an ICM in order to provide their clients with websites, interactive campaigns and promotions, and other business solutions using internet technologies. The ICM operates as a complete suite of interactive resources and knowledge for the agency, Deliver interactive assets for their business partners focused on mutually growing revenues. During this process, the ICM traditionally operates behind the scenes and does not have direct contact with the agency's client. Contract manufacturing as a business model has proven tremendously successful, as demonstrated in other industries such as automotive, electronics, textiles, and many others. The ICM serves to maximize business opportunities, economies of scale, and profitability for their partners.

A third reason for increasing opportunity in contract development services is found in the growth of emerging bioteche’s. Many of these companies are heavily focused on the development of drug compounds to address a specific therapeutic area. In 2015, solid dose formulations was the largest segment, constituting 49.8% of the total pharmaceutical contract manufacturing market, and is projected to grow at a CAGR of 3.4% from 2012 to 2017. Generics will likely be a key growth driver for the solid dose formulations segment; however, this segment will likely lose shares to the injectable dose formulations segment because of big pharma’s shift in focus from small molecules to large molecules

 

A spectrum of capabilities  Medical device companies have historically been profitable and only in recent times some of these companies began feeling the competitive pressures that have existed in other industries. These companies have in the past maintained low levels of outsourcing activities mainly as a result of what was perceived as a lack of incentives to implement cost-cutting strategies. However, over the last decade outsourcing has grown to become a widely accepted practise among medical device companies. Increased speed to market, reduced cost, quality improvement and the availability of highly skilled labour have all been factors which has driven the uptake of outsourcing in the medical device industry. We note that a number of contract manufacturers now offer multiple capabilities to cater to OEMs’ various needs.

  • A spectrum of capabilities for both board-level and computer system products
  • Crunching the numbers comparative to global revenues for contract manufacturing
  • Deliver interactive assets for their business partners
  • In acquiring raw materials by benefiting from economies of scale
  • Mutual Benefit to contract Site to have a steady flow of business

Related Conference of Interactive and Electronic Contract Manufacturing

June 06-07, 2018

International Conference & B2B on Pharma Research and Development

Philadelphia, Pennsylvania, USA
August 20-21, 2018

12th Asian Biologics and Biosimilars Congress

Tokyo, Japan
October 18-20, 2018

18th World Pharma Congress

Warsaw, Poland
November 15-16, 2018

14th International Conference on Generic Drugs and Biosimilars

Frankfurt, Germany
September 18-19, 2018

6 th European Biopharma Congress

Amsterdam, Netherlands

Interactive and Electronic Contract Manufacturing Conference Speakers